Bharat Biotech gets approval to progress Covaxin to Phase II trials
India-based Bharat Biotech has obtained regulatory approval to advance its Covid-19 vaccine candidate, Covaxin, into...
Bharat Biotech’s Covaxin vaccine yields positive Phase I data
India-based Bharat Biotech's Covid-19 vaccine candidate, Covaxin, has demonstrated an encouraging safety profile in a...
Zydus Cadila’s Covid-19 vaccine enters Phase II testing
India-based Zydus Cadila has launched Phase II clinical trials of its Covid-19 vaccine candidate, ZyCoV-D,...
SII seeks approval to trial Oxford Covid-19 vaccine in India
Serum Institute of India (SII) has filed an application with the Drugs Controller General of...
Glenmark’s FabiFlu yields positive data in Phase III Covid-19 trial
India-based Glenmark Pharmaceuticals has reported positive top-line data from a Phase III clinical trial of...
Zydus starts dosing in Phase I/II Covid-19 vaccine study
Zydus has started dosing participants in the Phase I/II clinical trials of its Covid-19 vaccine...
India’s Zydus gets Mexican approval to trial Desidustat for Covid-19
India-based pharmaceutical company Zydus has received approval from the Mexican regulatory authority, COFEPRIS, to assess...
India approves second Covid-19 vaccine for clinical trials
Zydus Cadila has secured regulatory approval from the Drug Controller General of India (DCGI) to...
India’s first Covid-19 vaccine by Bharat Biotech to enter trials
India-based biotechnology company Bharat Biotech has secured regulatory approval from the Drug Controller General of...
Bharat Serums to assess sepsis drug Ulinastatin for Covid-19
India-based Bharat Serums and Vaccines (BSVL) has secured regulatory approval to assess sepsis drug, Ulinastatin,...